P-30 Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer
| Autor: | Elshenawy, M., Badran, A., Jubran, A. Al, Alzahrani, A., Rauf, M., Eldali, A., Bazarbashi, S. |
|---|---|
| Zdroj: | In Annals of Oncology July 2020 31 Supplement 3:S99-S99 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|